Majorities of cancer cells exhibit alterations in the cellular lipid metabolism either by increasing lipid biogenesis or through enhanced lipid uptake by overexpressing genes and proteins involved in lipid biogenesis or uptake (such as SREBP, LXR, FASN, and LDLR) [16]. Here, FASN is linked to cancer.